Shandong Buchang Pharmaceuticals announced that the shareholder of its controlling subsidiary Shanghai HePu, Wang Baocai, intends to transfer his unpaid 0.05% equity to Zhao Xiaogang for 0 yuan, and 0.025% equity to Cheng Kai for 0 yuan. The company agrees to waive its priority right to purchase; after the trade is completed, the company will still hold 71.30% equity in Shanghai HePu. Duan Lin is the spouse of the company's Director and Vice President Xue Renhuan, and this waiver constitutes a related transaction. In the past 12 months, the company conducted 2 related transactions with Xue Renhuan and his spouse Duan Lin, with a transaction amount of 37.5605 million yuan.